| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/07/2005 | US20050075286 Isolated human tumor supressor proteins, nucleic acid molecules encoding these human tumor supressor proteins, and uses thereof |
| 04/07/2005 | US20050075275 Regulation of the apj receptor for use in the treatment or prophylaxis of cardiac diseases |
| 04/07/2005 | US20050075268 cell is contacted with a photosentistising agent, cell is irradiated with light to activate photosentisitising agent, the cell is contacted with the molecule to be introduced, particularly for use in cancer treatment, gene therapy and vaccination |
| 04/07/2005 | US20050074903 Assay method using biochemical analysis units and assay apparatus |
| 04/07/2005 | US20050074892 Transposon-mediated random codon-based mutagenesis |
| 04/07/2005 | US20050074891 Starch branching enzyme IIb |
| 04/07/2005 | US20050074888 Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the same |
| 04/07/2005 | US20050074887 Adenoviral VA1 Pol III promoter system for RNAi expression |
| 04/07/2005 | US20050074886 Recombinant vector derived from adeno-associated virus for gene therapy |
| 04/07/2005 | US20050074885 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 04/07/2005 | US20050074884 Identification of peptides that facilitate uptake and cytoplasmic and /or nuclear transport of proteins, DNA and viruses |
| 04/07/2005 | US20050074883 Replicating and propagating preferential nucleotide sequences using plasmid comprising restriction enzyme sites which generate hapaxoterministic ends; gene expression analysis |
| 04/07/2005 | US20050074879 Antisense oligonucleotide modulation of STAT3 expression |
| 04/07/2005 | US20050074878 Oligonucleotides which inhibits protein tyrosine phosphatase gene expression for use in treatment and prevention of autoimmune, cell proliferative and hematopoietic disorder |
| 04/07/2005 | US20050074865 Adzymes and uses thereof |
| 04/07/2005 | US20050074864 Expression vector comprising nucleotide sequences coding carybdea blood lysis protein for use as tool in treatment and prevetion of platelet agglutination disorders; pesticides |
| 04/07/2005 | US20050074863 Chemoprotective agent comprising lymphocyte epitopes for use in treatment of cell proliferative disorders |
| 04/07/2005 | US20050074862 Polynucleotides encoding defense responde proteins |
| 04/07/2005 | US20050074861 Human secretory type phospholipase A2 |
| 04/07/2005 | US20050074856 Methods and compositions for increasing protein yield from a cell culture |
| 04/07/2005 | US20050074855 High affinity fusion proteins and therapeutic and diagnostic methods for use |
| 04/07/2005 | US20050074853 Recombinant MHC molecules useful for manipulation of antigen-specific T-cells |
| 04/07/2005 | US20050074852 Serine/threonine kinase (PKN) peptides for use in identifying modulators for treatment and prevention of inflammation, cancer, arteriosclerosis and psoriasis |
| 04/07/2005 | US20050074849 Peptides |
| 04/07/2005 | US20050074848 Major histocompatibility complex fusion comprising human cartilage oligomeric matrix protein (COMP) for use in prevention and treatment of cancer, infection, autoimmune and transplant rejection |
| 04/07/2005 | US20050074846 Per-arent-sim (PAS) interaction domain comprising human ether-a-go-go related gene (HERG) sequences for use as tool in treatment and prevention of oxidative damage to cardiovascular system |
| 04/07/2005 | US20050074843 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 04/07/2005 | US20050074842 Membrane protein for use as tools in generation of vaccine; medical diagnosic and drug screening tools |
| 04/07/2005 | US20050074841 DNAs encoding mammalian histamine receptor of the H4 subtype |
| 04/07/2005 | US20050074840 Folded recombinant tumor necrosis polypeptide comprising substituted proline for use as tool in treatment of inflammatory disorders |
| 04/07/2005 | US20050074839 Novel survivin interacting protein tpr1 |
| 04/07/2005 | US20050074838 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
| 04/07/2005 | US20050074837 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/07/2005 | US20050074836 Containing modifications in the A3 and/or C1 and/or C2 domains of the sequence of the light chain of Factor VIII |
| 04/07/2005 | US20050074835 Transgenic yeast comprising glutathione synthetase for use as tool in improving food flavor and taste |
| 04/07/2005 | US20050074818 Methods and agents for the diagnosis and therapy of chronically inflammatory intestinal diseases |
| 04/07/2005 | US20050074814 Relaxin3-GPCR135 complexes and their production and use |
| 04/07/2005 | US20050074805 Specific markers for diabetes |
| 04/07/2005 | US20050074804 Propagating/replicating preferential nucleotide/gene sequences using circular plasmid; genetic engineering and heterologous gene expression |
| 04/07/2005 | US20050074802 Nucleotide sequences which code for the MetD gene |
| 04/07/2005 | US20050074801 Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometry |
| 04/07/2005 | US20050074797 FHIT proteins and nucleic acids and methods based thereon |
| 04/07/2005 | US20050074792 Storing and detecting nucleic acid administered to a solid carrier |
| 04/07/2005 | US20050074791 L-lysine-producing corynebacteria and process for the preparation of L-lysine |
| 04/07/2005 | US20050074787 Universal arrays |
| 04/07/2005 | US20050074786 Using variation in ligand activated transcription factor as tool in diagnosing and prognosing cardiovascular disorders |
| 04/07/2005 | US20050074785 Plasmid comprising asymetric restriction enzyme sites for use as tool in propagating preferential DNA fragments |
| 04/07/2005 | US20050074776 High washing efficiency with no contamination and liquid does not remain in the nozzle tip; washing solution is fed into a tip containing the solid phase unidirectionally from head to end |
| 04/07/2005 | US20050074775 assessing GST-pi expression levels in fixed or fixed and paraffin embedded tissues using primers; pharmacogenetics; determining antitumor platinum-based chemotherapeutic regimen |
| 04/07/2005 | US20050074770 Cloned mammalian histamine H4 receptor that couples to G-protein; for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders |
| 04/07/2005 | US20050074768 Monoclonal, polyclonal or neutralizing antibody or a antigen-binding Fab, Fc, F(ab)2, or Fv fragment that specifically binds to a histamine receptor having a specific sequence; may have a radiolabel, a fluroescent label, a chemiluminescent label, or an enzymatic label |
| 04/07/2005 | US20050074767 Using transcriptional activity of obesity genes as diagnostic indicator of efficacy of dietetic modulators; treating eating/weight disorders |
| 04/07/2005 | US20050074766 Gene of enzyme reactivating dna damaged by ultraviolet light using visible light |
| 04/07/2005 | US20050074764 Using presence of point mutations in nicotinic acetylcholine receptor (nACHR) gene as diagnostic/prognosic tool in detction and treatment of indicator of cardiovascular, nervous system, vision and pain disorders |
| 04/07/2005 | US20050074763 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses |
| 04/07/2005 | US20050074761 Novel means for the diagnosis and therapy of ctcl |
| 04/07/2005 | US20050074760 Enzymatic nucleic acids containing 5'-and/or 3'-cap structures |
| 04/07/2005 | US20050074758 Prokineticin polypeptides, related compositions and methods |
| 04/07/2005 | US20050074757 Compositions and methods for inhibiting expression of a mutant gene |
| 04/07/2005 | US20050074755 Nucleotide sequences coding mutator locus gene for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 04/07/2005 | US20050074754 Membrane protein for use in diagnosis, treatment and prevention of inflammation; immunosuppressants |
| 04/07/2005 | US20050074747 Identifying peptide sequences that selectively bind to preferential bio-targets for use in diagnosis of viral disease, diabetes, inflammatory, arthritic, atherosclerotic, cell proliferative, autoimmune and cardiovascular disorders |
| 04/07/2005 | US20050074464 Type I allergic diseases; grass pollen |
| 04/07/2005 | US20050074439 Utilized for expression of desired heterologous DNAs |
| 04/07/2005 | US20050074435 Enriching stem and progenitor cells by positive or negative selection of hematopoietic cells from umbilical cord blood; culturing under proliferation conditions that increase differentiation potential |
| 04/07/2005 | US20050074430 recombinant virus genetically engineered to have hypoxia induced factor replicates selectively in hypoxic cells or tissues |
| 04/07/2005 | US20050074427 IL-17 like molecules and uses thereof |
| 04/07/2005 | US20050074426 A conjugate of a cytokine and a tumor targeting moiety with numerous provisos |
| 04/07/2005 | DE10343326A1 Neuer endospermspezifischer Pflanzenpromotor für Kulturpflanzen New endosperm plant promoter for crops |
| 04/07/2005 | DE10342373A1 Verfahren zur Synthese von Nukleinsäuren und deren Anwendung A process for the synthesis of nucleic acids and their uses |
| 04/07/2005 | CA2814269A1 Identification of tumour-associated cell surface antigens for diagnosis and therapy |
| 04/07/2005 | CA2540706A1 Royal jelly peptide and composition containing the same |
| 04/07/2005 | CA2540701A1 Proteins expressed in nk cells |
| 04/07/2005 | CA2540446A1 Polypeptide cleavage method using ompt protease variant |
| 04/07/2005 | CA2540367A1 An enzyme for catalyzing biosynthesis of piperitol and/or sesamin |
| 04/07/2005 | CA2540177A1 Seneca valley virus based compositions and methods for treating disease |
| 04/07/2005 | CA2540087A1 Amplification of polynucleotides by rolling circle amplification |
| 04/07/2005 | CA2540049A1 Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs |
| 04/07/2005 | CA2539972A1 Antisense compound and method for selectively killing activated t cells |
| 04/07/2005 | CA2539864A1 Hiv pharmaccines |
| 04/07/2005 | CA2539752A1 Oligonucleotide compositions and methods for treating disease including inflammatory conditions |
| 04/07/2005 | CA2539727A1 Bispecific oligonucleotide for the treatment of cns malignancies |
| 04/07/2005 | CA2539651A1 Synthetic lethal screen using rna interference |
| 04/07/2005 | CA2539432A1 Altering a b cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agent |
| 04/07/2005 | CA2538215A1 Staple oligonucleotides and medicaments comprising the same |
| 04/07/2005 | CA2537876A1 Antibodies to m-csf |
| 04/07/2005 | CA2537363A1 Synthetic heparanase molecules and uses thereof |
| 04/07/2005 | CA2537340A1 Leader sequences for use in production of proteins |
| 04/07/2005 | CA2536139A1 Nucleic acid-lipophilic conjugates |
| 04/07/2005 | CA2533218A1 Oligonucleotide analog and method for treating flavivirus infections |
| 04/07/2005 | CA2525217A1 Genetic markers for skatole metabolism |
| 04/06/2005 | EP1521077A1 Detecting interactions between substances |
| 04/06/2005 | EP1520860A2 Recombinant protein PilC, method for its production and use thereof |
| 04/06/2005 | EP1520623A2 Detecting interaction between substance |
| 04/06/2005 | EP1520619A2 Biochannel assay for hybridization with biomaterial |
| 04/06/2005 | EP1520589A1 Erythropoietin in the treatment of domestic and livestock animals for anaemia |
| 04/06/2005 | EP1520246A2 Mutation detection and identification |
| 04/06/2005 | EP1520050A2 Tr4/tr2 response elements |
| 04/06/2005 | EP1520049A1 Nucleic acid amplification method |
| 04/06/2005 | EP1520044A2 Chromosome 6 and 9 genes involved in premature canities |